17 results about "Euphorbia" patented technology

1. The name of the design product: hydroponic container (Euphorbia pulcherrima wax sealed ball). 2. The use of the design product: the design product is used for hydroponic container. 3. The design points of the design product: in shape. 4. The picture or photo that best indicates the design points: assembly state perspective view.

The invention relates to a traditional Chinese medicine composition for treating ulcerative colitis in a remission stage as well as a preparation method and application of the traditional Chinese medicine composition. The traditional Chinese medicine composition comprises the following traditional Chinese medicine raw materials in parts by weight: 5-35 parts of humifuse euphorbia herb, 3-12 parts of carbonized sanguisorba root, 3-12 parts of gordon euryale seed, 1-6 parts of rhizoma bletillae, 0.5-5 parts of gallnut, 0.06-0.3 part of catechu and 0.02-0.12 part of pearl powder. According to the traditional Chinese medicine, the effects of all the medicines are synergistic, and all the medicines are combined to achieve the effects of attacking evil, tonifying deficiency, clearing waste heat, dispersing blood stasis, stopping bleeding, tonifying spleen and consolidating root; dynamic and static are combined, blood circulation is promoted, stasis is prevented, astringency is induced, and positive consumption is prevented. The multiple medicines synergistically play roles in healing sore, promoting tissue regeneration and repairing intestinal mucosa, directly refer to the core goal of healing ulcerative colitis, and are suitable for the pathogenesis characteristics of gradual decline of damp-heat and spleen deficiency reveal in the remission period of ulcerative colitis.

A new cultivar of Euphorbia plant named ‘Miner's Berry Bordeaux’ that is characterized by its new foliage and stems that are very dark burgundy red in color maintaining the color throughout the season with the foliage changing to dark rose pink in the fall before the plant goes dormant, its upright compact plant habit, its clusters of unique dark burgundy involucre bracts surrounding tiny yellow-green floral bracts, its cold hardiness at least to U.S.D.A. Zone 4, and its high resistance to deer.

The invention relates to an ethyl acetate extract of stems of Euphorbiaceae Baliospermum as well as a preparation method and application of the ethyl acetate extract in the technical field of biological medicine, the ethyl acetate extract is prepared by the following steps: fully soaking Baliospermum cornutum with 95% ethanol, then heating and refluxing and extracting with ethanol, concentrating an extracting solution until no alcohol smell exists, and then suspending with water to obtain the ethyl acetate extract of the stems of the Euphorbiaceae Baliospermum cornutum. Adding petroleum ether, ethyl acetate and n-butyl alcohol which are equal to the suspension in volume for extraction respectively, collecting supernatant liquid, and concentrating the obtained ethyl acetate extract phase under the condition of reduced pressure or normal pressure to remove the solvent, so as to obtain the ethyl acetate extract. The viburnum cordifolium stem ethyl acetate extract disclosed by the invention can be used for preparing a medicine for treating colitis or colon cancer. The provided ethyl acetate extract of the fordia cordata stems can inhibit colon cancer and improve the enterotoxicity of chemotherapeutic drugs. The medicine source is natural, the preparation process is mature, and the extraction process is convenient and easy to operate.

The euphorbia hupehensis phenolic acid compound (EHPA) (the compound as shown in the formula I) is separated from the root of euphorbia hupehensis for the first time, the separation and purification method is simple, the compound is high in safety and non-toxic to cells and animals through determination, and the compound is found to have antiviral activity and have an inhibiting effect on canine parvovirus (CPV) through an activity test, so that the euphorbia hupehensis phenolic acid compound (EHPA) can be used for preparing an anti-viral drug for treating the canine parvovirus (CPV). After being prepared into an oral preparation, the traditional Chinese medicine composition has a good treatment effect on CPV infection and is convenient to use.

The invention provides an assembled and annotated chloroplast genome of euphorbia splendens, and relates to the fields of molecular biology and plant genetics. The chloroplast genome of the pteris amurensis is a single cyclic molecule; the total length of the chloroplast genome of the psidium aquilinum is 149180bp; the nucleotide sequence of the chloroplast genome of the pteris amurensis is as shown in SEQ ID NO. 1; the GC content of the chloroplast genome of the pteris amurensis is 43.14%; the pteridium aquilinum chloroplast genome provided by the invention enriches a pteridium gene database, lays a foundation for exploring pteridium aquilinum evolution history and an adaptation mechanism of pteridium aquilinum to environmental stress, decrypts genetic codes of pteridium aquilinum from a molecular level, and is applied to biodiversity protection, plant ecological restoration and gardening.

The present application provides a kind of seedling raising method for improving the survival rate of Euphorbia hirta transplanting, relating to the technical field of Euphorbia hirta artificial planting.The seedling raising method is to use the nutrient agent prepared by calcium nitrate, potassium nitrate, magnesium sulfate, ammonium dihydrogen phosphate, perilla frutescens glycosides C, malt extract, EDTA iron sodium salt, and the base fertilizer compounded by the leaf baking and cooking material of Chinese rose, rice husk charcoal, coconut husk and ternary compound fertilizer.The present application overcomes the shortcomings of the prior art, can effectively ensure the seed germination of Euphorbia hirta while promoting the root growth of seedling, shorten the seedling period while improving the seedling rate, and comprehensively improve the economic benefit of artificial seedling.

The invention belongs to the technical field of traditional Chinese medicine, and particularly relates to a traditional Chinese medicine composition for treating acute lung injury and a preparation method and application thereof. The traditional Chinese medicine composition for treating the acute lung injury is prepared from the following raw materials in parts by weight: 10 to 15 parts of cortex moutan, 15 to 25 parts of radix paeoniae rubra, 25 to 35 parts of radix rehmanniae recen, 10 to 20 parts of semen persicae, 10 to 20 parts of fructus aurantii immaturus, 10 to 15 parts of radix curcumae, 10 to 15 parts of rhizoma acori graminei, 15 to 25 parts of fructus trichosanthis, 10 to 20 parts of fructus forsythiae, 10 to 20 parts of rhizoma polygoni cuspidati, 15 to 25 parts of semen lepidii and 25 to 35 parts of radix astragali seu hedysari. The traditional Chinese medicine composition has the beneficial effects that the traditional Chinese medicine composition for treating the acute lung injury can play a role in the aspects of improving the immune state, improving circulation and the like by influencing the release of inflammatory factors; the traditional Chinese medicine composition can improve the treatment effective rate and off-line success rate of acute lung injury patients, shorten the mechanical ventilation time, improve the oxygenation index of the patients, reduce the expression of proinflammatory factors IL-6, regulate the immune balance of Th1 / Th2 and Th17 / Treg, improve hemagglutination and relieve the disease severity and multi-organ dysfunction of the patients.

The invention discloses a Mongolian medicine compound for treating anaphylactoid purpura nephritis, and belongs to the technical field of traditional Chinese medicine. The Mongolian medicine compound for treating the anaphylactoid purpura nephritis is prepared from the following raw materials in parts by mass: 50 parts of flos carthami, 50 parts of bear gall, 40 parts of cockscomb, 3 parts of humifuse euphorbia herb, 35 parts of red sandalwood, 35 parts of blackberry lily, 25 parts of vermilion and 25 parts of semen momordicae. The Mongolian medicine compound designed by the invention shows an excellent and stable technical effect in the aspect of treating HSPN, can effectively relieve proteinuria of an HSPN model, improve renal functions and relieve pathological injury of kidney tissues through the action of multiple targets and multiple links, and has a good overall curative effect. The compound provides a potential drug choice which is clear in curative effect and relatively low in side effect risk for treating the anaphylactoid purpura nephritis, and has good application value.

This invention discloses a method for producing the diterpenoid compound jolkinol A using cell suspension culture, belonging to the field of plant cell culture technology. The method includes: using *Euphorbia hirta* stem segments or young leaves as explants, inoculating them onto MS medium containing 6-BA and NAA to induce callus formation; suspending the callus in liquid MS medium containing 6-BA and NAA; adding salicylic acid to the culture system for induction for 10-14 days; collecting the cells, and obtaining jolkinol A through methanol extraction and chromatographic separation. After induction with 550 μmol / L salicylic acid for 10 days, this invention achieved a jolkinol A yield of 47.00 mg / L, 5.4 times higher than the control group, providing technical support for the large-scale production of jolkinol A.

The invention discloses application of a traditional Chinese medicine composition in preparation of a medicine for treating pulmonary arterial hypertension, and relates to the technical field of traditional Chinese medicines. The invention provides a traditional Chinese medicine composition Jinshui ten-component decoction in a medicine for treating pulmonary arterial hypertension. The traditional Chinese medicine composition comprises the following components in parts by weight: 20-50 parts of raw astragalus membranaceus, 10-30 parts of codonopsis pilosula, 10-25 parts of salvia miltiorrhiza, 8-20 parts of safflower carthamus, 10-25 parts of herba lycopi, 6-15 parts of winged euonymus twig, 10-20 parts of semen lepidii, 10-25 parts of poria cocos, 3-10 parts of white mulberry root-bark and 10-25 parts of semen plantaginis. The traditional Chinese medicine compound is based on the treatment principle of tonifying qi, activating blood and inducing diuresis to alleviate edema of traditional Chinese medicine, realizes multi-target regulation and control, effectively reduces pulmonary arterial pressure, improves right heart function and reverses pulmonary vascular remodeling through synergistic compatibility of multiple traditional Chinese medicines, has the advantages of high safety, low price and suitability for long-term administration, and provides a new effective choice for treatment of pulmonary arterial hypertension.

The invention belongs to the technical field of medicines for burns and scalds, and particularly relates to a spray for burns and scalds and a preparation method thereof, the spray for burns and scalds comprises pollen typhae, herba cepbalanoplosis segeti, callicarpa nudiflora, humifuse euphorbia herb, verbena, herba seu stipulae, lalang grass rhizome, a natural astringent, azone, bisabolol and a plant extract. The preparation method comprises the following steps: removing impurities from the herba cepbalanoplosis segeti, callicarpa nudiflora, humifuse euphorbia herb, verbena officinalis, herba seu stigmae draconis and lalang grass rhizome, cleaning, drying and crushing, cleaning and drying the pollen typhae, and soaking the pollen typhae in alcohol; filtering to obtain a liquid medicine, adding borneol into the liquid medicine, then adding glycerol, azone, a plant extract, bisabolol and a natural astringent, and diluting the alcohol concentration in the liquid medicine with sterile distilled water; the spray for burns and scalds provided by the invention can timely treat wound surfaces and quickly stop bleeding, and has the characteristics of safety, no irritation, economy, convenience, natural healing, no scars and the like.

The application discloses a traditional Chinese medicine composition for relieving asthma, which comprises fried ephedra, asarum, inula flower, rhodiola, bitter apricot kernel, euphorbia, lonicera, earthworm, oldenlandia and licorice. The traditional Chinese medicine composition has the characteristics of ascending and descending combination, yin and yang combination, cold and warm combination and treatment of symptoms and root causes, and is suitable for children with asthma caused by latent pathogen, phlegm, blood stasis and air retention. The traditional Chinese medicine composition can improve the lung function, cough, expectoration and other symptoms of the children, effectively reduce the recurrence rate of bronchial asthma of the children with wind-phlegm-latent-lung type, and has no obvious adverse reactions and side effects. The application also protects an oral dose prepared from the traditional Chinese medicine composition and application thereof.

This useful solution refers to a procedure for isolating and purifying the compound kaempterol-3-O-rhamnoside from the bark of the medicinal tree Schima wallichii (DC.) Korth., which exhibits cytotoxic activity against HL-60 leukemia cells. The process according to the solution includes the following steps: a) preparing the raw material from the bark of the medicinal plant *Euphorbia hirta*; b) extracting the powdered raw material with 70% ethanol to obtain the ethanol extract labeled VT-E; c) dissolving the VT-E extract in hot water to obtain a liquid mixture; d) partition extraction with n-hexane to obtain the n-hexane extract labeled VT-H; e) partition extraction with dichloromethane to obtain the dichloromethane extract labeled VT-DCM; f) partition extraction with ethyl acetate to obtain the ethyl acetate extract labeled VT-EA. g) Isolating the fraction containing kaempferol-3-O-rhamnoside from the VT-EA extract using silica gel column chromatography to obtain the fraction labeled VT-EA-6; h) Purifying the VT-EA-6 fraction using column chromatography to obtain the fraction labeled VT-EA-6-3; i) Purifying the VT-EA-6-3 fraction using silica gel column chromatography to obtain the kaempferol-3-O-rhamnoside compound with formula (1). The compound kaempferol-3-O-rhamnoside obtained by the utility solution procedure exhibited significant cytotoxic activity against HL60 leukemia cell line under in vitro conditions.

The invention provides a diterpenoid compound extracted from euphorbia fischeriana as well as a preparation method and application of the diterpenoid compound, and belongs to the technical field of plant medicines. The diterpenoid compound (A3710) in the medicinal material euphorbia fischeriana is found for the first time, the diterpenoid compound (A3710) has a remarkable anti-lung cancer effect, and the cytotoxicity IC50 value of the diterpenoid compound (A3710) to lung cancer cells reaches the nanomole level; in a mouse subcutaneous transplantation tumor model of cell line-derived allograft tumor and patient-derived tumor xenotransplantation, the diterpenoid compound A3710 can effectively inhibit the growth of lung cancer cells, and shows a clear anti-lung cancer drug effect. The invention further provides a method for preparing the diterpenoid compound A3710 from the medicinal material euphorbia fischeriana, the extraction rate of the diterpenoid compound A3710 prepared according to the method can reach 0.05% or above, and operation is convenient and fast.

The invention relates to the technical field of poultry breeding and veterinary drugs, and discloses a pharmaceutical composition for preventing salpingitis of laying hens, which is prepared from astragalus membranaceus, salvia miltiorrhiza, silymarin, oyster, humifuse euphorbia herb, cistanche, angelica sinensis, parsley, geranium wilfordii and a compound enzyme preparation. Wherein the complex enzyme preparation is composed of lysozyme and glucose oxidase, and the preparation method comprises the following steps: firstly, carrying out low-temperature superfine grinding on the traditional Chinese medicine components, and then carrying out multi-stage mixing on the traditional Chinese medicine components and the complex enzyme preparation. The compound enzyme preparation is used for regulating the intestinal micro-ecology, reducing the load of pathogenic bacteria and blocking the ascending infection of the fallopian tube; the traditional Chinese medicine components are used for clearing away heat and toxic materials, astringing, repairing, tonifying qi and activating blood and promoting fallopian tube mucosa repair. The composition can effectively reduce the occurrence rate of salpingitis of laying hens and improve the eggshell quality, and the preparation process avoids enzyme preparation inactivation and ensures the biological activity and stability of the product.

The invention relates to a velvet flower extract as well as a preparation method and application thereof, and the preparation method comprises the following steps: adding water and hydrochloric acid into velvet flowers, adjusting the pH value to 3.6-4.0, cleaning and drying to obtain dried velvet flowers; adding water and citric acid into the dried velvet flowers, adjusting the pH value to 3.6-4.0, decocting, filtering, and collecting supernate; adding asparaginic acid to adjust the pH value to 3.6-4.0, continuing to decoct, and filtering to obtain a first filter residue and a first extract; adding a hexanediol solution into the first filter residue, carrying out reflux extraction, and filtering to obtain a second filter residue and a second extract; adding a hexanediol solution into the second filter residue, performing ultrasonic treatment, and collecting supernate to obtain a third extract; and mixing the first extract, the second extract and the third extract to obtain the velvet flower extract. The prepared velvet flower extract is suitable for cosmetics.